
Cancer is a prevalent disease in elderly patients, who are also more likely to have zzso illnesses than younger zzso Both increasing age and zzso are associated with a lower use of aggressive cancer zzso surgery, chemotherapy, and radiation zzso age is often the stronger zzso A large proportion of elderly but otherwise healthy cancer patients do not receive aggressive zzso Although there is an zzso of elderly patients in clinical trials, the available evidence suggests that elderly patients can derive similar survival benefits from aggressive treatments as younger zzso For certain zzso and treatments, elderly patients may experience higher rates of toxicity and therefore require closer zzso Patients with zzso illnesses have worse zzso quality of life at baseline but experience a similar zzso quality of life decline from treatment as healthier zzso However, patients with significant zzso are less likely to derive benefit from aggressive zzso There is a need for studies to better zzso at zzso patients who are likely to benefit from and tolerate aggressive zzso A systematic use of sophisticated zzso such as the geriatric assessment, may allow physicians to select appropriate patients and reduce zzso of aggressive treatments in elderly cancer zzso 

